OBJECTIVES : To compare the economic impact of rapid deployment valve (RDV) versus using conventional valve, a third-party payer perspective in Brazil and Colombia.

METHODS : A model was done to compare each valve replacement treatment during inpatient of 30-day and the complication rates such as: intensive care (ICU) and ward length of stay, vascular complications, cardiovascular-attributed mortality, myocardial infarction, stroke, need for pacemaker obtained from best evidence review of the published literature and cost from Health System in Brazil (Private System) and Colombia (Entidades Promotoras de Salud [Health Promoting Entities] EPS) and outputs consists of local currencies (BRL/Brazil, COP/Colombia).

RESULTS : In the current scenario with RDV, the economic benefit associated per patient were BRL 21,935 and COP 31,038.048 for Brazil and Colombia, respectively. It was found a 1.8% reduction on cardiovascular-associated mortality when using RDV. Other benefits associated with RDV included reduction in ICU length of stay (-38.7%) and time to recover in surgical room (-2 days).

CONCLUSIONS : For this preliminary analyze RDV has the potential to promote better resources allocation, by reducing mortality at reasonable costs in patients who need aortic valve replacement.